(Q36492084)

14 August 2017

Quantitative analysis of a parasitic antiviral strategy (English)

1 reference

14 August 2017

Hwijin Kim

1

1 reference

14 August 2017

John Yin

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

14 August 2017

4

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

14 August 2017

48

1 reference

14 August 2017

3

1 reference

14 August 2017

1017-1020

1 reference

Strategies in the design of antiviral drugs

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Evolution of bacteriophage in continuous culture: a model system to test antiviral gene therapies for the emergence of phage escape mutants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Virus population dynamics, fitness variations and the control of viral disease: an update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Drug resistance in viruses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

30 September 2017

The making of a phage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

The hypercycle. Coupling of RNA and protein biosynthesis in the infection cycle of an RNA bacteriophage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Viral escape from antisense RNA.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Kinetics of RNA replication: competition and selection among self-replicating RNA species

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Novel vector for generating RNAs with defined 3' ends and its use in antiviral strategies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

A novel immune system against bacteriophage infection using complementary RNA (micRNA).

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353149

Pathogen-derived resistance to viral infection using a negative regulatory molecule

21 September 2018

1 reference

12 December 2020

Replication and evolution of short-chained RNA species replicated by Q beta replicase

1 reference

12 December 2020

Kinetic and thermodynamic characterization of the interaction between Q beta-replicase and template RNA molecules

1 reference

12 December 2020

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

1 reference

12 December 2020

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

12 December 2020

10.1128/AAC.48.3.1017-1020.2004

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

14982798

1 reference